Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Short term Debt (2016 - 2025)

Dare Bioscience (DARE) has disclosed Short term Debt for 8 consecutive years, with $10542.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt changed N/A year-over-year to $10542.0, compared with a TTM value of $10542.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $4054.0, changed N/A over the prior year.
  • Short term Debt was $10542.0 for Q3 2025 at Dare Bioscience, down from $187966.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $1.0 million in Q1 2021 and bottomed at $4054.0 in Q4 2024.
  • Average Short term Debt over 3 years is $382411.5, with a median of $139936.5 recorded in 2025.